Noradrenaline drives immunosuppression in sepsis: clinical consequences
Open Access
- 1 June 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 46 (6), 1246-1248
- https://doi.org/10.1007/s00134-020-06025-2
Abstract
No abstract availableFunding Information
- Rijnstate-Radboudumc (160721-6)
This publication has 14 references indexed in Scilit:
- Potentially Inadvertent Immunomodulation: Norepinephrine Use in SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for SepsisJAMA, 2016
- Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapyNature Reviews Immunology, 2013
- Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic ShockJAMA, 2013
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- The late phase of sepsis is characterized by an increased microbiological burden and death rateCritical Care, 2011
- Macroscopic Postmortem Findings in 235 Surgical Intensive Care Patients with SepsisAnesthesia & Analgesia, 2009
- Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trialCritical Care, 2009
- Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenesJournal of Neuroimmunology, 2001
- Norepinephrine Inhibits Human Natural Killer Cell Activity in VitroInternational Journal of Neuroscience, 1991